SEC Form 4 Reporting Owner · CIK 0001282930
Carl L Gordon
Director at ADARx Pharmaceuticals Inc · Director at Electra Therapeutics Inc · Director at BlossomHill Therapeutics Inc · +14 more
Bought (12 mo)
+$61.1M
Sold (12 mo)
—
Form 4 Filings
74
Companies
17
Filing Activity
2026-09-30
first filed 2021-01-26
Trading record
Open-market buys
+$155M
26 filings
Open-market sales
−$32.4M
9 filings
Sales under a 10b5-1 plan
67%
6 of 9 sale filings
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| ADRXADARx Pharmaceuticals Insider trading | Director | 1 | 950,000 | — | +950,000 | 14,325,529 2026-09-30 |
| ETRAElectra Therapeutics Insider trading | Director | 1 | 1,333,333 | — | +1,333,333 | 5,126,891 2026-09-23 |
| BLSMBlossomHill Therapeutics Insider trading | Director | 2 | 625,000 | — | +625,000 | 2,714,279 2026-08-12 |
| SCTXScribe Therapeutics Insider trading | Director | 2 | 1,000,000 | — | +1,000,000 | 1,348,825 2026-07-29 |
| CMPXCompass Therapeutics Insider trading | Director | 10 | 6,077,018 | 3,571,428 | +2,505,590 | 15,219,994 2025-04-11 |
| KROSKeros Therapeutics Insider trading | Director | 7 | — | 250,000 | −250,000 | 45,057 2025-12-18 |
| MBXMBX Biosciences Insider trading | Director | 3 | 940,672 | — | +940,672 | 3,255,000 2025-02-19 |
| Lomond Therapeutics Insider trading | Director | 1 | — | — | — | 2,677,256 2024-11-05 |
| ACETAdicet Bio Insider trading | Director | 10 | 4,000,000 | — | +4,000,000 | 11,458,940 2024-06-07 |
| TERNTerns Pharmaceuticals Insider trading | Director | 9 | 4,302,931 | 56,164 | +4,246,767 | 755,635 2024-07-17 |
| PHGETessera Insider trading | 10%+ | 3 | 348,000 | 24,344 | +323,656 | 13,797,997 2024-05-20 |
| KNTEKinnate Biopharma Insider trading | Director | 7 | 3,061,800 | — | +3,061,800 | 0 2024-04-05 |
| THRXTheseus Pharmaceuticals Insider trading | Director | 9 | 1,500,066 | — | +1,500,066 | 0 2024-02-14 |
| AVBPArriVent Insider trading | Director | 1 | 444,444 | — | +444,444 | 1,513,664 2024-01-31 |
| GMTXDisc Medicine Insider trading | Director | 1 | — | — | — | — |
| ORICOric Pharmaceuticals Insider trading | Director | 6 | — | 553,146 | −553,146 | 2,212,571 2021-03-31 |
| PRVLPrevail Therapeutics Inc | Director | 1 | — | — | — | 0 2021-01-26 |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.